| Followers | 236 |
| Posts | 10817 |
| Boards Moderated | 0 |
| Alias Born | 07/17/2006 |
Thursday, November 21, 2019 7:59:33 AM
kim...
Excellemt post...
I can honestly say that the Krill People, ACST, are liars and their lying goes back many years...
Way back..at least seven or eight years ago there was an article published in a Canadian journal of nutrition that purported to show the effect on the lipid profile of people put on Krill Oil...The results were fabulous Krill oil significantly lowered not only Trigs...but also significantly lowered LDL-C...
And this was in six or seven different cohorts...The only trouble was the lipid results were not consistent with the Friedewald Equation which describes the relationship of Total Cholesterol, LDL-C, HDL-C and trigs...
The Friedewald equation has been shown to be highly accurate in thousands of cases..
And in this Krill oil report the errors were always on the side that favored Krill oil...So this was definitely a scam...
Krill oil has no magic effect..Krill Oil, as sold, is in the Triglyceride FFA configuration and its proponents claim it yields higher blood levels because it is better absorbed... A claim the FDA does not agree with..It might be better absorbed in certain situations but the effect is trivial...The other claim is the EPA is better, This is nonsense The Krill get their EPA the same place fish do..from other sources..They don't make any of their own...
Krill Oil is a scam and the people behind it know it...I would not put it beyond them to put up a phony analysis...
As for the market...They know next to nothing,,Look at the late AdCom panel members...Dumber than a fart and they are MDs...Imagine how stupid the general public is...
":>) JL
Excellemt post...
I can honestly say that the Krill People, ACST, are liars and their lying goes back many years...
Way back..at least seven or eight years ago there was an article published in a Canadian journal of nutrition that purported to show the effect on the lipid profile of people put on Krill Oil...The results were fabulous Krill oil significantly lowered not only Trigs...but also significantly lowered LDL-C...
And this was in six or seven different cohorts...The only trouble was the lipid results were not consistent with the Friedewald Equation which describes the relationship of Total Cholesterol, LDL-C, HDL-C and trigs...
The Friedewald equation has been shown to be highly accurate in thousands of cases..
And in this Krill oil report the errors were always on the side that favored Krill oil...So this was definitely a scam...
Krill oil has no magic effect..Krill Oil, as sold, is in the Triglyceride FFA configuration and its proponents claim it yields higher blood levels because it is better absorbed... A claim the FDA does not agree with..It might be better absorbed in certain situations but the effect is trivial...The other claim is the EPA is better, This is nonsense The Krill get their EPA the same place fish do..from other sources..They don't make any of their own...
Krill Oil is a scam and the people behind it know it...I would not put it beyond them to put up a phony analysis...
As for the market...They know next to nothing,,Look at the late AdCom panel members...Dumber than a fart and they are MDs...Imagine how stupid the general public is...
":>) JL
Recent AMRN News
- Amarin Highlights New REDUCE-IT Analysis Showing Risk-Weighted ApoB May Improve Cardiovascular Risk Detection (AMRN) • IH Market News • 05/27/2026 03:24:38 PM
- New REDUCE-IT® Analysis Presented at the European Atherosclerosis Society (EAS) Congress 2026 Suggests Risk-Weighted ApoB May Improve Identification of Residual Cardiovascular Risk in Statin-Treated Patients with Hypertriglyceridemia • GlobeNewswire Inc. • 05/27/2026 12:00:00 PM
- Earnings Report Shows Narrowing Losses as Amarin (AMRN) Advances Partner-Led Growth Strategy • IH Market News • 04/29/2026 02:19:17 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/29/2026 11:06:34 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/29/2026 11:05:15 AM
- Amarin Reports 2026 First Quarter Financial Results • GlobeNewswire Inc. • 04/29/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/22/2026 09:00:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:02 PM
- Amarin to Report First Quarter 2026 Financial Results and Host Conference Call on April 29, 2026 • GlobeNewswire Inc. • 04/15/2026 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/10/2026 09:01:34 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/10/2026 09:00:20 PM
- American College of Cardiology (ACC) Scientific Sessions 2026 Underscore the Need for Complementary Therapies Including Icosapent Ethyl (IPE) in Treatment of Elevated Triglycerides and Cardiovascular Risk Reduction • GlobeNewswire Inc. • 04/08/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:30:11 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/30/2026 09:57:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2026 09:00:07 PM
- Amarin Highlights Guideline Recommended Role of Icosapent Ethyl in Managing Cardiovascular Risk Following Release of Updated 2026 ACC/AHA/Multisociety Dyslipidemia Guideline • GlobeNewswire Inc. • 03/18/2026 12:30:00 PM
- New REDUCE-IT Data in Patients at Extreme Cardiovascular Risk and In Vitro Research on the Mechanistic Effects of Eicosapentaenoic Acid (EPA) on Lipoprotein(a) [Lp(a)] Oxidation to be Presented at the American College of Cardiology’s (ACC) Annual Scienti • GlobeNewswire Inc. • 03/16/2026 12:15:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/02/2026 10:31:01 PM
- Effects of Icosapent Ethyl on Risk and Duration of Hospitalizations and Death in REDUCE-IT® Post Hoc Analysis Published in the European Journal of Preventive Cardiology • GlobeNewswire Inc. • 03/02/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 12:05:26 PM
